All omicron articles – Page 2
-
NewsOmicron induces cellular senescence in human lung, study finds
Researchers investigating the influence of defined altered spike formations have confirmed that the Omicron variant induces cellular senescence in human lungs of COVID-19 patients.
-
NewsBroad-spectrum antiviral candidate targets dengue and SARS-CoV-2
A broad-spectrum antiviral drug candidate, 2-thiouridine, that targets positive-strand RNA viruses has been identified and characterized.
-
News Targeting a coronavirus ion channel could yield new Covid-19 drugs
Chemists discover the structures of open and closed states of the channel, which could help the development of antiviral drugs to reduce inflammation.
-
NewsVulnerability to different COVID-19 mutations depends on previous infections and vaccination
A person’s immune response to variants of SARS-CoV-2 depends on their previous exposure – and differences in the focus of immune responses will help scientists understand how to optimise vaccines in the future to provide broad protection.
-
NewsCOVID-19 could hold key to spotting viruses with pandemic potential
Certain SARS-CoV-2 variants of concern are evolving to do a better job of shutting down human innate immune responses, according to new research.
-
NewsStudy helps explain SARS-CoV-2 variants’ rapid spread
Omicron variants, which circulated quickly around the globe, bind to cells more avidly and evade antibodies more efficiently than earlier variants, new research reveals.
-
NewsFitness landscape explains Covid variant origins
Researchers have uncovered the mechanisms behind the emergence of new and dangerous coronavirus variants, such as Alpha, Delta, Omicron, and others.
-
NewsFirst human respiratory organoid culture system reveals secret of Omicron’s transmissibility
Researchers have established the first human respiratory organoid culture system and unveiled a novel mechanism for the high transmissibility of SARS-CoV-2 Omicron variant.
-
NewsOmicron appears more deadly than seasonal influenza, study suggests
Adults hospitalised with the SARS-CoV-2 Omicron variant have a higher death rate than those hospitalised with seasonal influenza, even though Omicron is considered less virulent with lower case fatality rates than the delta and alpha strains, new research being presented at ECCMID suggests.
-
NewsMask rule in hospitals may have little impact on COVID-19 transmission during Omicron wave
A study in large London hospital during first 10 months of Omicron activity suggests the real-world benefit of mask-wearing in isolation is likely to be modest, according to new research being presented at this year’s ECCMID.
-
NewsInexpensive way to produce anti-Covid nanobodies cuts down on the llamas
Researchers have come up with a less expensive way to isolate and identify nanobodies that target various parts of the SARS-CoV-2 spike protein and are currently derived from llamas.
-
NewsStudy shows New York City rats carry SARS-CoV-2
Wild rats in the New York City municipal sewer systems and elsewhere in the city have been exposed to SARS-CoV-, a new study has revealed.
-
NewsThree compounds from sea sponge and marine bacteria offer Covid-blocking powers
University of British Columbia researchers have identified three compounds that prevent COVID-19 infection in human cells, derived from natural sources including a BC sea sponge.
-
NewsResearchers develop tailored Covid neutralizer that can adapt to mutations
A research team at Pohang University of Science and Technology has developed a tailored COVID-19 neutralizer that can adapt to all kinds of mutations in the virus in treating the viral infection.
-
NewsNew Omicron subvariant resistant to all approved therapeutic antibodies
Rrsearchers in Germany have found that the Omicron sub-lineage BQ.1.1, currently on the rise worldwide, is resistant to all the approved antibody therapies used to treat individuals at risk for severe Covid-19 disease.
-
NewsResearchers find SARS-CoV-2 Omicron BA.2 subvariant less severe than earlier variants
team led by investigators at Massachusetts General Hospital (MGH) has determined that the SARS-CoV-2 Omicron BA.2 subvariant is less severe than the previous Delta variant and less severe to an even greater extent than the original Omicron variant.
-
NewsIntranasal COVID vaccine works against variants in animals
Researchers have developed an intranasal vaccine against Covid-19 that can fight off the original virus and two variants in hamsters.
-
NewsmRNA vaccines significantly reduce severity of Delta, Omicron COVID-19 infections
People who have received several doses of an mRNA COVID-19 vaccine are more likely to have milder illnesses if infected with Delta or Omicron variants than those who are unvaccinated.
-
NewsNew Omicron subvariant largely evades neutralizing antibodies, raising spectre of increased Covid infections this winter
A study at Karolinska Institutet in Sweden shows that the coronavirus variant BA.2.75.2, an Omicron sublineage, largely evades neutralizing antibodies in the blood and is resistant to several monoclonal antibody antiviral treatments.
- Previous Page
- Page1
- Page2
- Next Page
